Ferozsons Laboratories Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: PK0005201014
PKR
379.11
22.81 (6.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
6,682.57
5,939.28
4,505.07
5,091.90
4,730.95
4,528.99
3,811.89
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,682.57
5,939.28
4,505.07
5,091.90
4,730.95
4,528.99
3,811.89
Raw Material Cost
3,641.99
3,329.82
2,776.26
3,025.41
2,645.90
2,680.36
2,358.27
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
98.39
104.69
99.17
109.72
171.49
193.91
220.66
Selling and Distribution Expenses
2,235.52
1,964.20
1,105.89
1,582.13
1,625.00
1,273.69
948.25
Other Expenses
-9.84
-10.47
-9.92
-10.97
-17.15
-19.39
-22.07
Total Expenditure (Excl Depreciation)
5,877.50
5,294.02
3,882.15
4,607.54
4,270.90
3,954.05
3,306.52
Operating Profit (PBDIT) excl Other Income
805.1
645.3
622.9
484.4
460.09999999999997
574.9
505.4
Other Income
-83.78
-2.06
-56.86
26.14
38.81
-20.61
-17.26
Operating Profit (PBDIT)
972.19
893.49
799.04
782.66
713.04
738.88
597.40
Interest
98.39
104.69
99.17
109.72
171.49
193.91
220.66
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
3,040.59
2,609.46
1,728.81
2,066.49
2,085.06
1,848.63
1,453.62
Depreciation
263.39
258.01
253.86
267.91
214.39
197.97
143.14
Profit Before Tax
610.42
530.80
446.01
405.03
327.16
346.99
233.60
Tax
265.97
208.85
190.68
157.22
149.61
105.97
36.59
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
269.00
258.69
206.22
199.47
150.45
220.40
183.33
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
269.00
258.69
206.22
199.47
150.45
220.40
183.33
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
75.45
63.26
49.11
48.34
27.10
20.63
13.68
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
344.45
321.95
255.34
247.81
177.55
241.02
197.01
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
12,729.01
12,633.89
12,375.20
12,169.53
11,970.07
11,448.70
11,228.31
Earnings per share (EPS)
6.19
5.95
4.74
4.59
3.46
5.07
4.22
Diluted Earnings per share
6.19
5.95
4.74
4.59
3.46
5.07
4.22
Operating Profit Margin (Excl OI)
11.86%
10.73%
13.36%
9.6%
9.72%
12.4%
12.37%
Gross Profit Margin
13.08%
13.28%
15.54%
13.22%
11.45%
12.03%
9.88%
PAT Margin
4.03%
4.36%
4.58%
3.92%
3.18%
4.87%
4.81%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 12.51% vs 31.84% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 6.99% vs 26.09% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 17.91% vs 4.64% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -6.02% vs 5.54% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Ferozsons Laboratories Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(PKR)
Change(%)
Net Sales
6,682.57
6,372.57
310.00
4.86%
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,682.57
6,372.57
310.00
4.86%
Raw Material Cost
3,641.99
3,733.34
-91.35
-2.45%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
98.39
23.41
74.98
320.29%
Selling and Distribution Expenses
2,235.52
1,430.73
804.79
56.25%
Other Expenses
-9.84
-2.34
-7.50
-320.51%
Total Expenditure (Excl Depreciation)
5,877.50
5,164.07
713.43
13.82%
Operating Profit (PBDIT) excl Other Income
805.07
1,208.50
-403.43
-33.38%
Other Income
-83.78
-103.96
20.18
19.41%
Operating Profit (PBDIT)
972.19
1,206.53
-234.34
-19.42%
Interest
98.39
23.41
74.98
320.29%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
3,040.59
2,639.23
401.36
15.21%
Depreciation
263.39
102.14
161.25
157.87%
Profit Before Tax
610.42
1,080.97
-470.55
-43.53%
Tax
265.97
391.53
-125.56
-32.07%
Provisions and contingencies
0
0
0.00
Profit After Tax
269.00
689.44
-420.44
-60.98%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
269.00
689.44
-420.44
-60.98%
Share in Profit of Associates
0
0
0.00
Minority Interest
75.45
0.00
75.45
Other related items
0.00
0.00
0.00
Consolidated Net Profit
344.45
689.44
-344.99
-50.04%
Equity Capital
0
0
0.00
Face Value
10.00
0.00
0.00
Reserves
12,729.01
8,193.72
4,535.29
55.35%
Earnings per share (EPS)
6.19
71.48
-65.29
-91.34%
Diluted Earnings per share
6.19
71.48
-65.29
-91.34%
Operating Profit Margin (Excl OI)
11.86%
18.96%
0.00
-7.10%
Gross Profit Margin
13.08%
18.57%
0.00
-5.49%
PAT Margin
4.03%
10.82%
0.00
-6.79%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 668.26 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 12.51% vs 31.84% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 41.25% vs 22.24% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 34.44 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 6.99% vs 26.09% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 93.92% vs 59.14% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 105.60 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 17.91% vs 4.64% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 56.63% vs 41.16% in Dec 2024

Quarterly - Interest
Interest 9.84 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -6.02% vs 5.54% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -42.62% vs 27.04% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.86%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024